Anti-Ll37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA

Frontiers in Immunology- Switzerland

doi 10.3389/fimmu.2018.01936

Related search

Anti-Citrullinated Peptide Antibodies May Occur in Patients With Psoriatic Arthritis

Annals of the Rheumatic Diseases

English

Prevalence of Comorbidites Among Patients With Psoriasis (Pso) With and Without Psoriatic Arthritis (Psa) in European Union (Eu)

English

PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)

English

A5.4 Anti Carbamylated Protein Antibodies (Anti-CarP) Are Present in Arthralgia Patients and Predict the Development of Rheumatoid Arthritis

Annals of the Rheumatic Diseases

English

Biomarkers of Subclinical Atherosclerosis in Patients With Psoriatic Arthritis

Open Access Rheumatology: Research and Reviews

Rheumatology

2019

English

THU0282 the Impact of Comorbidities on Physical Function in Patients With Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PSA) Attending Rheumatology Clinics

2018

English

Pms50 - Cost-Effectiveness Analysis of Apremilast in the Treatment of Psoriatic Arthritis (Psa) in the Slovak Republic and Slovenia

English

Comparison of Disease Status and Outcomes of Patients With Psoriatic Arthritis (PSA) Receiving Adalimumab or Etanercept Monotherapy in the United States (US)

English

Arraying Prostate Specific Antigen PSA and Fab Anti-Psa Using Light-Assisted Molecular Immobilization Technology

English

Amanote Research

Anti-Ll37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA

Frontiers in Immunology- Switzerland

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Anti-Citrullinated Peptide Antibodies May Occur in Patients With Psoriatic Arthritis

Prevalence of Comorbidites Among Patients With Psoriasis (Pso) With and Without Psoriatic Arthritis (Psa) in European Union (Eu)

PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)

A5.4 Anti Carbamylated Protein Antibodies (Anti-CarP) Are Present in Arthralgia Patients and Predict the Development of Rheumatoid Arthritis

Biomarkers of Subclinical Atherosclerosis in Patients With Psoriatic Arthritis

THU0282 the Impact of Comorbidities on Physical Function in Patients With Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PSA) Attending Rheumatology Clinics

Pms50 - Cost-Effectiveness Analysis of Apremilast in the Treatment of Psoriatic Arthritis (Psa) in the Slovak Republic and Slovenia

Comparison of Disease Status and Outcomes of Patients With Psoriatic Arthritis (PSA) Receiving Adalimumab or Etanercept Monotherapy in the United States (US)

Arraying Prostate Specific Antigen PSA and Fab Anti-Psa Using Light-Assisted Molecular Immobilization Technology